Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.clml.2016.02.041 | DOI Listing |
Cytometry B Clin Cytom
September 2019
Flow Cytometry Unit, Hematology Laboratory, ICO-Hospital Germans Trias i Pujol, Institut de Recerca Josep Carreras, Universitat Autònoma de Barcelona, Badalona, Spain.
Background: The concept of borderline lymphoproliferative disorder (LPD) has not been clearly defined.
Methods: This study aimed to classify patients with leukemic LPD (n = 597, excluding hairy cell leukemia, mantle cell lymphomas, and CD10-positive LPDs) into CLL or non-CLL applying three diagnostic strategies (the D'Arena and CLLflow scores and CD43 expression) and to better characterize unclassified patients.
Results: Patients with concurring CLL-like (n = 441) or non-CLL like (n = 99) results with the three diagnostic strategies were determined to have CLL and non-CLL, respectively.
Clin Lymphoma Myeloma Leuk
May 2016
Department of Pathology, University of California San Diego Health System, La Jolla, CA. Electronic address:
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!